Pyrimidone "Medi-Pets" en es it fr

Pyrimidone "Medi-Pets" Brand names, Pyrimidone "Medi-Pets" Analogs

Pyrimidone "Medi-Pets" Brand Names Mixture

  • No information avaliable

Pyrimidone "Medi-Pets" Chemical_Formula


Pyrimidone "Medi-Pets" RX_link

Pyrimidone "Medi-Pets" fda sheet

Pyrimidone "Medi-Pets" msds (material safety sheet)

Pyrimidone_"Medi-Pets" MSDS

Pyrimidone "Medi-Pets" Synthesis Reference

Boon et al., Brit. pat. 666,027 (1952 to I.C.I.)

Pyrimidone "Medi-Pets" Molecular Weight

218.252 g/mol

Pyrimidone "Medi-Pets" Melting Point

281.5 oC

Pyrimidone "Medi-Pets" H2O Solubility

500 mg/L

Pyrimidone "Medi-Pets" State


Pyrimidone "Medi-Pets" LogP


Pyrimidone "Medi-Pets" Dosage Forms

Tablet; Chewable tablets; Oral suspension

Pyrimidone "Medi-Pets" Indication

For the treatment of epilepsy

Pyrimidone "Medi-Pets" Pharmacology

Primidone is a barbiturate with anticonvulsant properties. Primidone, either alone or used concomitantly with other anticonvulsants, is indicated in the control of grand mal, psychomotor, and focal epileptic seizures. It may control grand mal seizures refractory to other anticonvulsant therapy. Primidone raises electro- or chemoshock seizure thresholds or alters seizure patterns in experimental animals. Primidone per se has anticonvulsant activity as do its two metabolites, phenobarbital and phenylethylmalonamide (PEMA). In addition to its anticonvulsant activity, Primidone potentiates that of phenobarbital in experimental animals.

Pyrimidone "Medi-Pets" Absorption

90 to 100%

Pyrimidone "Medi-Pets" side effects and Toxicity

No information avaliable

Pyrimidone "Medi-Pets" Patient Information

Pyrimidone "Medi-Pets" Organisms Affected

Humans and other mammals